Meningococcal Surveillance Australia Reporting period 1 April to 30 June 2023

Authors

  • Monica M Lahra The World Health Organization Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, NSW Health Pathology Microbiology, The Prince of Wales Hospital, Randwick, NSW 2031, Australia
  • Prashanthi Sai Krishnan 1. The World Health Organization Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, NSW Health Pathology, Microbiology, The Prince of Wales Hospital, Randwick, NSW 2031, Australia
  • Tiffany R Hogan 1. The World Health Organization Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, NSW Health Pathology, Microbiology, The Prince of Wales Hospital, Randwick, NSW 2031, Australia

DOI:

https://doi.org/10.33321/cdi.2024.48.21

Keywords:

antimicrobial resistance, disease surveillance, meningococcal disease, Neisseria meningitidis

Abstract

The reference laboratories of the National Neisseria Network, Australia report data on invasive meningococcal disease (IMD) cases confirmed by culture and or molecular techniques for the Australian Meningococcal Surveillance Programme (AMSP). Culture-positive cases and molecular-based diagnoses are defined as IMD by the Communicable Diseases Network Australia National Guidelines for Public Health Units. Data contained in the quarterly reports are restricted to a description of the number of cases by jurisdiction and serogroup, when known. Some minor corrections to data in Table 1 may be made in subsequent reports if additional data are received.

Downloads

Download data is not yet available.

References

Australian Government Department of Health and Aged Care, Communicable Diseases Network Australia (CDNA). Invasive Meningococcal Disease: CDNA National Guidelines for Public Health Units. Canberra: Australian Government Department of Health and Aged Care; 4 July 2017. Available from: https://www.health.gov.au/sites/default/files/documents/2020/02/invasive-meningococcal-disease-cdna-national-guidelines-for-public-health-units.pdf.

Lahra MM, Hogan TR. Australian Meningococcal Surveillance Programme annual report, 2019. Commun Dis Intell (2018). 2020;44. doi: https://doi.org/10.33321/cdi.2020.44.62

George CRR, Booy R, Nissen MD, Lahra MM. The decline of invasive meningococcal disease and influenza in the time of COVID‐19: the silver linings of the pandemic playbook Med J Aust. 2022;216(10):504–7. https://doi.org/10.5694/mja2.51463.

Lahra MM, and Hogan TR. Meningococcal Surveillance Australia: Reporting period 1 January to 31 March 2023. Commun Dis Intell (2018). 2023;47. doi: https://doi.org/10.33321/cdi.2023.47.59.

Downloads

Published

13/05/24

How to Cite

Lahra, Monica M, Prashanthi Sai Krishnan, and Tiffany R Hogan. 2024. “Meningococcal Surveillance Australia Reporting Period 1 April to 30 June 2023”. Communicable Diseases Intelligence 48 (May). https://doi.org/10.33321/cdi.2024.48.21.

Issue

Vol. 48 (2024)

Section

Quarterly report

Categories

License

Copyright (c) 2024 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 10 > >>